Vitafoods Europe
Sabinsa to Launch ImmunoSpore in EU Market at Vitafoods Europe
The postbiotic is evidenced to support a healthy gut barrier, balanced immune signaling, and mucosal defenses.
By: Mike Montemarano
Associate Editor, Nutraceuticals World
Photo: tanya78 | Adobe Stock
Booth 3F104
At Vitafoods Europe, Sabinsa will have a European debut of ImmunoSpore. The company is the official longevity sponsor of the event, and will have a longevity-focused portfolio of ingredients on display.
ImmunoSpore is the company’s latest immune health innovation. It is a postbiotic derived from heat-inactivated Heyndrickxia coagulans (MTCC 5856) standardized to 15 billion spores per gram. The formulation supports a healthy intestinal barrier, promotes balanced immune signaling, and helps maintain mucosal defenses, the company reported, addressing immune resilience in the context of healthy aging.
Other longevity-aligned ingredients Sabinsa will showcase include:
- Curcumin C3 Reduct, the first EFSA-approved tetrahydrocurcuminoid formulation derived from curcumin, offers colorless, bioactive metabolites with enhanced bioavailability and efficacy to help support antioxidant activity and overall cellular health.
- Cirpusins, a patented, standardized extract from dried rhizomes of Cyperus rotundus, has been clinically studied to support safe, natural weight management and healthy lipid metabolism.
- Saberry, an Emblica officinalis (amla) extract standardized to 10% beta-glucogallin, is formulated to support healthy lipid and glucose metabolism and provide antioxidant support.
- Nigellin, a Nigella sativa (black cumin) seed extract standardized for 5% and 20% thymoquinone, is formulated to support a healthy immune response and overall wellness.
- Shagandha, an ashwagandha root extract standardized to 2.5% withanolides using USP methodology, is designed to support stress resilience and a balanced mood.
- Sabeet is a standardized beetroot extract backed by two recently published studies demonstrating benefits for heart health and improved markers of muscle quality and neuromuscular performance in postmenopausal women.


